データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
X4 Pharmaceuticals to Report Third-Quarter 2024 Financial and Phase 2 Chronic Neutropenia Study Results During Conference Call and Webcast on November 13, 2024
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Is a Favorite Amongst Institutional Investors Who Own 51%
X4 Pharmaceuticals to Participate in Upcoming September Investor Conferences
X4 Pharmaceuticals, Inc. (XFOR) Q2 2024 Earnings Call Transcript
10-Q:Q2 2024 四半期報告書
X4 Pharmaceuticals GAAP EPS of $0.45 Beats by $0.46
データなし
データなし